Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
Baxter
Colorcon
Medtronic
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Aminophylline In Sodium Chloride 0.45% patents expire, and when can generic versions of Aminophylline In Sodium Chloride 0.45% launch?

Aminophylline In Sodium Chloride 0.45% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

US ANDA Litigation and Generic Entry Outlook for Aminophylline In Sodium Chloride 0.45%

A generic version of AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% was launched as aminophylline by HOSPIRA on December 15th, 2019.

Summary for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
Drug patent expirations by year for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
Recent Clinical Trials for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beni-Suef UniversityPhase 1
Wuhan Union Hospital, ChinaPhase 4
Le Bonheur Children's HospitalPhase 3

See all AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% clinical trials

US Patents and Regulatory Information for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% aminophylline INJECTABLE;INJECTION 088147-002 May 3, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-002 Dec 12, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% aminophylline INJECTABLE;INJECTION 088147-003 May 3, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-001 Dec 12, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER aminophylline INJECTABLE;INJECTION 018924-004 Dec 12, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
McKesson
AstraZeneca
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.